1. Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat

   • Andrew J. S. Coats
   • Heli Tolppanen

   Current Opinion 03 September 2021 Pages: 1599 - 1604

   

2. Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

   • Stefan F. H. Neys
   • Jasper Rip
   • Odilia B. J. Corneth

   Leading Article Open access 05 October 2021 Pages: 1605 - 1626

   

3. Pharmacological Management of Acute Endodontic Pain

   • Asma A. Khan
   • Anibal Diogenes

   Review Article 07 October 2021 Pages: 1627 - 1643

   

4. Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review

   • Laura P. B. Elbers
   • Hennie G. Raterman
   • Willem F. Lems

   Review Article Open access 15 September 2021 Pages: 1645 - 1655

   

5. Tralokinumab: First Approval

   • Sean Duggan

   AdisInsight Report Open access 18 August 2021 Pages: 1657 - 1663

   

6. Savolitinib: First Approval

   • Anthony Markham

   AdisInsight Report 29 August 2021 Pages: 1665 - 1670

   

7. Telitacicept: First Approval

   • Sohita Dhillon

   AdisInsight Report 31 August 2021 Pages: 1671 - 1675

   

8. Belumosudil: First Approval

   • Hannah A. Blair

   AdisInsight Report Open access 31 August 2021 Pages: 1677 - 1682

   

9. Imeglimin Hydrochloride: First Approval

   • Yvette N. Lamb

   AdisInsight Report 01 September 2021 Pages: 1683 - 1690

   

10. Comment on: “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”

    • Song Zhang
    • Feng Zhu

    Letter to the Editor 28 August 2021 Pages: 1691 - 1692

11. Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”

    • Nadine Ahmed
    • John Paul Pezacki

    Letter to the Editor 28 August 2021 Pages: 1693 - 1695

12. Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

    • Jurij Hanzel
    • Christopher Ma
    • Brian G. Feagan

    Correction 28 August 2021 Pages: 1697 - 1697

13. Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD

    • Young-A Heo

    Correction Open access 28 August 2021 Pages: 1699 - 1699

14. Correction to: Aducanumab: First Approval

    • Sohita Dhillon

    Correction 15 September 2021 Pages: 1701 - 1701